News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
838,426 Results
Type
Article (86080)
Company Profile (649)
Press Release (751697)
Multimedia
Podcasts (127)
Webinars (14)
Section
Business (232209)
Career Advice (4124)
Deals (39708)
Drug Delivery (126)
Drug Development (90790)
Employer Resources (198)
FDA (17995)
Job Trends (17320)
News (395538)
Policy (39670)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (6)
2025 BioForest Digital (7)
2025 Lone Star Bio Digital (8)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2992)
Academic (1)
Accelerated approval (6)
Adcomms (25)
Allergies (78)
Alliances (56653)
ALS (78)
Alzheimer's disease (1466)
Antibody-drug conjugate (ADC) (139)
Approvals (17981)
Artificial intelligence (219)
Autoimmune disease (27)
Automation (11)
Bankruptcy (402)
Best Places to Work (12511)
BIOSECURE Act (22)
Biosimilars (118)
Biotechnology (447)
Bladder cancer (64)
Brain cancer (25)
Breast cancer (225)
Cancer (1931)
Cardiovascular disease (140)
Career advice (3529)
Career pathing (33)
CAR-T (155)
Cell therapy (434)
Cervical cancer (17)
Clinical research (72766)
Collaboration (768)
Compensation (439)
Complete response letters (28)
COVID-19 (2827)
CRISPR (42)
C-suite (216)
Cystic fibrosis (99)
Data (1789)
Decentralized trials (2)
Denatured (44)
Depression (37)
Diabetes (183)
Diagnostics (6750)
Digital health (9)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (117)
Drug pricing (93)
Drug shortages (17)
Duchenne muscular dystrophy (80)
Earnings (95244)
Editorial (36)
Employer branding (25)
Employer resources (167)
Events (128282)
Executive appointments (606)
FDA (18917)
Featured Employer (63)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (635)
Gene editing (97)
Generative AI (22)
Gene therapy (308)
GLP-1 (735)
Government (5105)
Grass and pollen (4)
Guidances (35)
Healthcare (20743)
Huntington's disease (25)
IgA nephropathy (26)
Immunology and inflammation (125)
Indications (24)
Infectious disease (2941)
Inflammatory bowel disease (147)
Inflation Reduction Act (11)
Influenza (42)
Intellectual property (84)
Interviews (812)
IPO (17687)
IRA (38)
Job creations (5184)
Job search strategy (2861)
Kidney cancer (11)
Labor market (39)
Layoffs (536)
Leadership (20)
Legal (10057)
Liver cancer (70)
Lung cancer (282)
Lymphoma (130)
Machine learning (4)
Management (65)
Manufacturing (280)
MASH (66)
Medical device (14296)
Medtech (14301)
Mergers & acquisitions (22272)
Metabolic disorders (587)
Multiple sclerosis (75)
NASH (22)
Neurodegenerative disease (96)
Neuropsychiatric disorders (23)
Neuroscience (1948)
NextGen: Class of 2025 (7666)
Non-profit (5054)
Northern California (2265)
Now hiring (39)
Obesity (317)
Opinion (270)
Ovarian cancer (68)
Pain (65)
Pancreatic cancer (60)
Parkinson's disease (131)
Partnered (19)
Patents (193)
Patient recruitment (90)
Peanut (48)
People (64866)
Pharmaceutical (131)
Pharmacy benefit managers (13)
Phase I (22476)
Phase II (31638)
Phase III (23791)
Pipeline (987)
Policy (138)
Postmarket research (3542)
Preclinical (10097)
Press Release (72)
Prostate cancer (83)
Psychedelics (34)
Radiopharmaceuticals (250)
Rare diseases (354)
Real estate (7383)
Recruiting (75)
Regulatory (26397)
Reports (55)
Research institute (2646)
Resumes & cover letters (649)
Rett syndrome (1)
RNA editing (4)
RSV (34)
Schizophrenia (68)
Series A (123)
Series B (70)
Service/supplier (25)
Sickle cell disease (46)
Southern California (1932)
Special edition (18)
Spinal muscular atrophy (164)
Sponsored (34)
Startups (4282)
State (2)
Stomach cancer (11)
Supply chain (50)
Tariffs (29)
The Weekly (81)
United States (19469)
Vaccines (724)
Venture capitalists (40)
Weight loss (228)
Women's health (36)
Worklife (19)
Date
Today (151)
Last 7 days (446)
Last 30 days (2077)
Last 365 days (29260)
2025 (8075)
2024 (34029)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Alabama (53)
Alaska (6)
Arizona (244)
Arkansas (8)
Asia (49813)
Australia (8792)
California (5160)
Canada (1547)
China (478)
Colorado (164)
Connecticut (208)
Delaware (124)
Europe (113984)
Florida (641)
Georgia (145)
Hawaii (1)
Idaho (64)
Illinois (437)
India (25)
Indiana (268)
Iowa (9)
Japan (131)
Kansas (109)
Kentucky (16)
Louisiana (8)
Maine (58)
Maryland (827)
Massachusetts (4076)
Michigan (182)
Minnesota (308)
Mississippi (1)
Missouri (53)
Montana (24)
Nebraska (26)
Nevada (52)
New Hampshire (50)
New Jersey (1485)
New Mexico (27)
New York (1466)
North Carolina (989)
North Dakota (7)
Northern California (2265)
Ohio (162)
Oklahoma (13)
Oregon (44)
Pennsylvania (1093)
Puerto Rico (11)
Rhode Island (23)
South America (1648)
South Carolina (4)
South Dakota (1)
Southern California (1932)
Tennessee (30)
Texas (686)
Utah (112)
Virginia (100)
Washington D.C. (38)
Washington State (507)
West Virginia (1)
Wisconsin (38)
838,426 Results for "sensei bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference
April 2, 2025
·
1 min read
Press Releases
Sensei Biotherapeutics Reports Full Year 2024 Financial Results and Update on Clinical Progress
March 31, 2025
·
8 min read
Press Releases
Sensei Biotherapeutics Reports Favorable Preliminary Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors
March 28, 2025
·
9 min read
Press Releases
Sensei Biotherapeutics to Participate in Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
February 4, 2025
·
1 min read
Press Releases
Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones
January 8, 2025
·
5 min read
Genetown
Sensei Biotherapeutics to Participate in Jefferies Global Healthcare Conference
Sensei Biotherapeutics, Inc. today announced that John Celebi, President and Chief Executive Officer, will present at the Jefferies Global Healthcare Conference, being held in New York, NY, on Thursday, June 6, 2024 at 8:30 a.m. ET.
May 30, 2024
·
1 min read
Press Releases
Sensei Biotherapeutics to Participate in Citi’s 2024 Global Healthcare Conference
November 28, 2024
·
1 min read
Business
Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
Sensei Biotherapeutics, Inc. reported financial results for the first quarter ended March 31, 2024, and provided corporate updates.
May 9, 2024
·
9 min read
Press Releases
Sensei Biotherapeutics to Present at Two Upcoming Scientific Conferences
October 29, 2024
·
2 min read
Genetown
Sensei Biotherapeutics to Participate in the 3rd Annual VISTA Symposium
Sensei Biotherapeutics, Inc. today announced that Company management will participate on a panel titled ‘Anti-VISTA Immunotherapies in Clinical Development’ at the 3rd Annual VISTA Symposium.
March 22, 2024
·
2 min read
1 of 83,843
Next
